Transcontinental (TCL.B) Stock Chart & Stock Price History → Little-known biotech company just had groundbreaking results from a study (From Smallcaps Daily) (Ad) Free TCL.B Stock Alerts C$13.40 -0.01 (-0.07%) (As of 10:57 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Transcontinental Stock Price Performance5 Day PerformanceN/A1 Month Performance-3.80%3 Month Performance-4.56%6 Month Performance+22.04%Year-To-Date PerformanceN/A1 Year Performance-10.67% Receive TCL.B Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Transcontinental and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyLittle-known biotech company just had groundbreaking results from a studyLearn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol TCL.B Stock Chart for Wednesday, May, 22, 2024 TCL.B Chart by TradingView Transcontinental Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2024C$13.58C$13.41-1.25%C$13.54C$13.41700 shsC$179.16 million05/16/2024C$13.58C$13.58C$13.63C$13.58300 shsC$181.43 million05/15/2024C$13.80C$13.58-1.59%C$13.63C$13.58300 shsC$181.43 million05/14/2024C$13.72C$13.80+0.58%C$13.81C$13.801,100 shsC$184.37 million05/13/2024C$13.72C$13.72C$13.91C$13.722,200 shsC$183.30 million05/06/2024C$13.72C$13.72C$13.91C$13.722,200 shsC$183.30 million Get the Latest News and Ratings for TCL.B and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Transcontinental and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024C$13.72C$13.72C$13.91C$13.722,200 shsC$183.30 million05/02/2024C$14.58C$13.72-5.90%C$13.91C$13.722,200 shsC$183.30 million04/29/2024C$14.58C$14.58C$14.58C$14.58100 shsC$194.79 million04/26/2024C$14.23C$14.58+2.46%C$14.58C$14.58100 shsC$194.79 million04/25/2024C$14.23C$14.23C$14.23C$14.23100 shsC$190.11 million04/24/2024C$13.93C$14.23+2.15%C$14.23C$14.23100 shsC$190.11 million04/23/2024C$13.93C$13.93C$13.93C$13.93400 shsC$186.11 million04/22/2024C$13.93C$13.93C$13.93C$13.93400 shsC$186.11 million04/19/2024C$14.25C$13.93-2.25%C$13.93C$13.93400 shsC$186.11 million04/18/2024C$14.25C$14.25C$14.25C$14.25500 shsC$190.38 million04/17/2024C$14.24C$14.25+0.07%C$14.29C$14.253,300 shsC$190.38 million04/15/2024C$14.24C$14.24C$14.24C$14.24100 shsC$190.25 million04/12/2024C$14.24C$14.24C$14.24C$14.24100 shsC$190.25 million04/11/2024C$13.98C$14.24+1.86%C$14.24C$14.24100 shsC$190.25 million04/09/2024C$13.98C$13.98C$13.98C$13.98200 shsC$186.77 million04/08/2024C$13.98C$13.98C$13.98C$13.98200 shsC$186.77 million04/05/2024C$14.15C$13.98-1.20%C$13.98C$13.98200 shsC$186.77 million04/04/2024C$15.21C$14.15-6.97%C$16.67C$14.15710 shsC$189.04 million04/03/2024C$15.21C$15.21C$15.21C$15.21100 shsC$203.21 million04/02/2024C$15.21C$15.21C$15.21C$15.21100 shsC$203.21 million04/01/2024C$15.20C$15.21+0.07%C$15.21C$15.21100 shsC$203.21 million03/28/2024C$15.20C$15.20C$15.20C$15.201,200 shsC$203.07 million03/27/2024C$14.93C$15.20+1.81%C$15.20C$15.201,200 shsC$203.07 million03/26/2024C$14.70C$14.93+1.56%C$14.93C$14.91500 shsC$199.47 million03/25/2024C$14.94C$14.70-1.61%C$14.91C$14.70800 shsC$196.39 million03/20/2024C$14.94C$14.94C$14.94C$14.94100 shsC$199.60 million03/19/2024C$14.94C$14.94C$14.94C$14.94100 shsC$199.60 million03/18/2024C$15.30C$14.94-2.35%C$14.94C$14.94100 shsC$199.60 million03/15/2024C$15.01C$15.30+1.93%C$15.30C$15.02500 shsC$204.41 million03/14/2024C$14.36C$15.01+4.53%C$15.01C$14.63950 shsC$200.53 million03/13/2024C$14.25C$14.36+0.77%C$15.00C$14.324,330 shsC$191.85 million03/11/2024C$14.25C$14.25C$14.25C$14.25100 shsC$190.38 million03/06/2024C$14.25C$14.25C$14.25C$14.25100 shsC$190.38 million03/05/2024C$14.25C$14.25C$14.25C$14.25100 shsC$190.38 millionLittle-known biotech company just had groundbreaking results from a study (Ad)Learn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol03/04/2024C$14.40C$14.25-1.04%C$14.25C$14.25100 shsC$190.38 million03/01/2024C$14.40C$14.40C$14.42C$14.40800 shsC$192.38 million02/29/2024C$14.60C$14.40-1.37%C$14.42C$14.40800 shsC$192.38 million02/28/2024C$14.39C$14.60+1.46%C$14.60C$14.60100 shsC$195.06 million02/27/2024C$14.28C$14.39+0.77%C$14.39C$14.39100 shsC$192.25 million02/26/2024C$14.28C$14.28C$14.28C$14.28458 shsC$190.78 million02/23/2024C$14.04C$14.28+1.71%C$14.28C$14.28460 shsC$190.78 million02/22/2024C$14.09C$14.04-0.35%C$14.04C$14.04200 shsC$187.57 million Related Companies: PNC.B Stock Chart PNC.A Stock Chart DII.B Stock Chart KEG.UN Stock Chart GH Stock Chart WPRT Stock Chart TRZ Stock Chart SRV.UN Stock Chart CKI Stock Chart SXP Stock Chart Receive TCL.B Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Transcontinental and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:TCL.B) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Presidential candidate you should REALLY be worried aboutStansberry ResearchThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarLittle-known biotech company just had groundbreaking results from a studySmallcaps DailyBill Clinton Backing Biden Replacement???The Freeport SocietyThe Crypto 9-5 Escape PlanCrypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transcontinental Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.